Share
WASHINGTON — The U.S. Food and Drug Administration has cleared a new rapid test from Abbott Laboratories, which the company says can detect the coronavirus in about 5 minutes.
Medical device maker Abbott announced the emergency clearance of its cartridge-based test in a release Friday night.
The company says that its test delivers a negative result in 13 minutes when the virus is not detected.
The U.S. has been trying for weeks to ramp up coronavirus testing after a series of problems with the initial government-designed test. The nation’s daily testing capacity has been increasing as more diagnostic makers and large laboratories have developed tests.
Abbott’s testing cartridge fits into the company’s portable ID NOW device, which is used at hospitals, clinics, and doctors’ offices. The company said it would launch the test next week to select health care facilities that deliver urgent care.
US Needs to Ramp up Testing
The Abbott approval follows two other rapid tests cleared by regulators in the past week. Older laboratory-developed tests can take between 4 to 8 hours to deliver results.
Health experts say the U.S. should be testing 100,000 to 150,000 people per day to track and contain the virus. There are no official nationwide testing metrics, but private and public health labs currently report testing about 80,000 to 90,000 patients per day.
RELATED TOPICS:
Trump Tariff Fears Erase $2 Trillion From US Stocks
13 hours ago
Senate Confirms Mehmet Oz to Take Lead of Medicare and Medicaid Agency
14 hours ago
First California EV Mandates Hit Automakers This Year. Most Are Not Even Close
16 hours ago
Pence Will Receive the Profile in Courage Award From the JFK Library for His Actions on Jan. 6
16 hours ago
Pentagon’s Watchdog to Review Hegseth’s Use of Signal App to Convey Plans for Houthi Strike
16 hours ago
President Trump’s Tariffs Could Be the Political Tipping Point
17 hours ago
Order That Kept Water in the Kern River Reversed by 5th District Court of Appeal
18 hours ago

Trump Fires NSC Officials a Day After Far-Right Activist Raises Concerns to Him

China Halts Approvals for New US Investment Projects

Trump Tariff Fears Erase $2 Trillion From US Stocks

Senate Confirms Mehmet Oz to Take Lead of Medicare and Medicaid Agency
